Dr Reddy's Labs names Milan Kalawadia as CEO, North America
Hyderabad: Dr. Reddy's Laboratories Ltd., has announced the appointment of Milan Kalawadia as Chief Executive Officer, North America, and member of the Management Council.
As part of the Dr. Reddy’s senior leadership team, he will be responsible for the company’s North America business and will be based out of the Princeton, New Jersey, U.S. office.
“I am excited to start this next chapter in my journey at Dr. Reddy’s,” says Milan Kalawadia. “I have been fortunate to be a part of a remarkable team that has achieved significant milestones over that last 18 years. I now look forward to leveraging the relationships I have built over my years within the organization, as well as the industry connections I have made to continue to lead the North America division to new heights.”
During his 18-year tenure at Dr. Reddy’s, Milan has held various positions of increasing responsibility beginning in 2006 with roles in Finance, Investor Relations, Corporate/Business Development, Marketing and Head of NAG OTC and SRx divisions. Most recently, Milan served as Chief Commercial Officer, responsible for the customer-facing and commercialization operations for the three main verticals of the core NA business: retail Rx, hospital/institutional injectable, and private label OTC. Milan led the early efforts to develop strategies for the Biosimilars and the Self-care & Wellness business units in the US. He played a critical role in driving various new growth initiatives including the acquisition of OTC brands; the development of our e-commerce presence on Amazon; and engaging with alternate channel partners.
“During the last three years, Milan’s efforts as Chief Commercial Officer were instrumental in driving North America to three consecutive years of growth over the $1 billion revenue threshold and achieving record sales in FY24,” says Erez Israeli, Chief Executive Officer, Dr. Reddy’s Laboratories Ltd. “His track record and deep understanding of the industry, coupled with his passion for innovation and customer-centric approach, make him the ideal candidate to lead the North America business unit into its next chapter of success.”
Milan holds a Bachelor of Science degree in Management Science and Information Systems from Rutgers University, School of Business; and a Master of Business Administration degree from Carnegie Mellon University, Tepper School of Business.
Established in 1984, Dr. Reddy’s Laboratories Ltd. is a global pharmaceutical company headquartered in Hyderabad, India. The Company offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
Dr Reddy's Labs major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe.
Read also: Dr Reddy's Labs Russian arm collaborate Novartis Pharma for anti-diabetes products
